- Home
- VTSI vs ARMP Comparison
VTSI vs ARMP Comparison
Compare VTSI & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTSI
- ARMP
- Stock Information
- Founded
- VTSI 1993
- ARMP N/A
- Country
- VTSI United States
- ARMP United States
- Employees
- VTSI N/A
- ARMP N/A
- Industry
- VTSI Miscellaneous manufacturing industries
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VTSI Consumer Discretionary
- ARMP Health Care
- Exchange
- VTSI Nasdaq
- ARMP Nasdaq
- Market Cap
- VTSI 70.9M
- ARMP 80.0M
- IPO Year
- VTSI N/A
- ARMP N/A
- Fundamental
- Price
- VTSI $6.83
- ARMP $2.03
- Analyst Decision
- VTSI Strong Buy
- ARMP Strong Buy
- Analyst Count
- VTSI 2
- ARMP 1
- Target Price
- VTSI $14.50
- ARMP $7.00
- AVG Volume (30 Days)
- VTSI 76.0K
- ARMP 9.2K
- Earning Date
- VTSI 11-12-2024
- ARMP 11-13-2024
- Dividend Yield
- VTSI N/A
- ARMP N/A
- EPS Growth
- VTSI N/A
- ARMP N/A
- EPS
- VTSI 0.53
- ARMP N/A
- Revenue
- VTSI $31,771,647.00
- ARMP $5,467,000.00
- Revenue This Year
- VTSI N/A
- ARMP N/A
- Revenue Next Year
- VTSI $24.06
- ARMP $83.33
- P/E Ratio
- VTSI $13.00
- ARMP N/A
- Revenue Growth
- VTSI N/A
- ARMP 34.92
- 52 Week Low
- VTSI $5.63
- ARMP $1.97
- 52 Week High
- VTSI $17.68
- ARMP $4.48
- Technical
- Relative Strength Index (RSI)
- VTSI 45.65
- ARMP 38.26
- Support Level
- VTSI $6.79
- ARMP $1.97
- Resistance Level
- VTSI $8.00
- ARMP $2.30
- Average True Range (ATR)
- VTSI 0.34
- ARMP 0.11
- MACD
- VTSI -0.09
- ARMP -0.02
- Stochastic Oscillator
- VTSI 14.50
- ARMP 7.50
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company includes installation, training, limited warranties, service agreements and related support. The company sells and supports use of force training and marksmanship firearms training systems and accessories for law enforcement, military or civilian use. The product line of the company includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire and other accessories.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.